期刊文献+

179例孕中期唐氏综合征筛查高风险孕妇妊娠结局的分析 被引量:4

Analysis of pregnancy outcome of pregnant women at high risk for Down syndrome screening
原文传递
导出
摘要 目的研究孕妇孕中期唐氏综合征筛查预测异常胎儿的价值,分析唐氏综合征筛查高风险与不良妊娠结局的关系。方法采用化学发光免疫技术定量检测孕中期(14-22周)孕妇血清中的三项指标(AFP、HCG、uE3),通过配套软件估算唐氏综合征、爱德华氏综合征、神经管缺陷的风险度,参考风险阈值筛选出高风险孕妇。通过产前诊断结果以及回访数据分析唐氏综合征筛查高风险与妊娠结局之间的相关性。结果筛查为高风险的179例孕妇中有:唐氏综合征4例,爱德华氏综合征1例,神经管缺陷2例,其他染色体异常2例,超声提示其他畸形3例,1例孕妇在羊膜腔穿刺术2周后流产。结论孕中期唐氏综合征筛查高风险是一项提示胎儿可能存在异常十分敏感的指标,普及唐氏综合征筛查对降低新生儿缺陷率、提高人口素质有着重要意义。 Objective: To investigate the value of Down syndrome screening at 2st trimester and analysis the relationship of high risk for Down syndrome screening and adverse pregnancy outcome. Methods: The study detected the concentration of AFP, HCG and uE3 in serum of pregnant women at 2st trimester ( gestational week : 14 - 22) by chemiluminescence assay ; estimated the risk of Down' s syndrome, Edward's syndrome and neural tube defect by software; screened pregnant women with high risk. Acquire the pregnancy outcome through tracing the results of prenatal diagnosis and calling back. Results: Among 179 cases with high risk for Down syndrome screening, there were 4 cases with Down syndrome, I case with Edward's syndrome, 2 cases with neural tube defect, 2 cases with oth- er chromosome abnormality, 3 cases with other malformation by ultrasound, and 1 case with abortion after amniotic cavity puncture. Conclusion: High risk for Down syndrome screening is a very sensitive indicator, which hints that the fetus may be with abnormality. Spreading'the screening is important for reducing the rate of birth defect and improving the population quality.
出处 《中国优生与遗传杂志》 2013年第5期54-55,66,F0004,共4页 Chinese Journal of Birth Health & Heredity
关键词 唐氏综合征筛查 新生儿缺陷 产前诊断 Down syndrome screening Birth defect Prenatal diagnosis
  • 相关文献

参考文献7

二级参考文献68

共引文献114

同被引文献42

  • 1Huang T, Hoffman B, Meschino W, et al. Prediction of ad- verse pregnancy outcomes by combinations of first and second trimester biochemistry markers used in the routine prenatal screening of Down syndrome [J] . Prenat Diagn, 2010, 30 (5) : 471 -477.
  • 2Wright D, Bradbury I, Malone F, et al . Cross - trimester re- peated measures testing for Downg syndrome screening: an as- sessment [J] Health Technol Assess, 2010, 14 (33) : 1 -80.
  • 3Alldred SK, Decks J J, Guo B, et al. Second trimester serum tests for Down's syndrome screening [J] . Coehrane Database Syst Rev, 2012, 6: CD009925.
  • 4Androutsopoulos G, Gkogkos P, Decavalas G. Mid - trimester maternal serum HCG and alpha fetal protein levels: clinical significance and prediction of adverse pregnancy outcome [J] -Int J Endoerinol Metab, 2013 , 1l (2) : 102 -106.
  • 5Wan X, Wen J, Song X, et al. The analysis of second - tri- mester triple screening for Down syndrome in Chinese normal singleton pregnancies [J] .Scand J Clin Lab Invest, 2012, 72 (8): 642-647.
  • 6Kaur G, Srivastav J, Sharma S, et al. Maternal serum median levels of alpha -foetoprotein, human chorionic gonadotropin & unconjugated estriol in second trimester in pregnant women from north-west India [J] . Indian J Med Res, 2013, 101 (138): 83-88.
  • 7Wald NJ, Cuckle HS, Densem JW, et al. Maternal serum screening for Down's syndrome in early pregnancy [J] . BMJ, 1988, 297 (6653): 883-887.
  • 8Renshaw R,Ellis K,Jacobs P,et al.Antenatal screening for Down syndrome:a quantitative demonstration of the improvements over the past20 years[J].J Health Serv Res Policy,2013,18(4):195-201.
  • 9Alldred SK,Deeks JJ,Guo B,et al.Second trimester serum tests for Down’s Syndrome screening[J].Cochrane Database Syst Rev,2012,6:CD009925.
  • 10D’Alton ME,Fuchs KM,Abuhammad A,et al.Implementation of a national nuchal translucency education and quality monitoring program[J].Obstet Gynecol,2014,123(1):149-154.

引证文献4

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部